• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED; PULMONIC VALVED CONDUIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED; PULMONIC VALVED CONDUIT Back to Search Results
Model Number 200S
Device Problem Calcified (1077)
Patient Problem Insufficient Information (4580)
Event Date 05/15/2019
Event Type  Injury  
Manufacturer Narrative
Citation: lueck s et al.Hydroxylapatite deposition induces graft alterations in chd patients.Cardiology in the young.2019; 29(supp.1):s84.Doi: 10.1017/s1047951119000489, earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding a retrospective analysis into the calcification-dependent alterations of various types of grafts in patients with congenital heart disease.All data were collected from a single center.The study population included 7 patients, 3 of whom were implanted with medtronic contegra pulmonary valved conduit (unique device identifier numbers not provided).Among all medtronic contegra patients, adverse events included: conduit explantation due to calcium-based deposits (calcium phosphates and hydroxylapatite).Based on the available information medtronic product was directly associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED
Type of Device
PULMONIC VALVED CONDUIT
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12443406
MDR Text Key270488126
Report Number2025587-2021-02764
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 09/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number200S
Device Catalogue Number200S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/24/2021
Initial Date FDA Received09/08/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-